Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy
- PMID: 31598148
- PMCID: PMC6775532
- DOI: 10.7150/jca.32650
Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy
Abstract
Bacterial-mediated cancer therapy (BMCT) has become a hot topic in the area of antitumor treatment. Salmonella has been recommended to specifically colonize and proliferate inside tumors and even inhibit tumor growth. Salmonella typhimurium (S. typhimurium) is one of the most promising mediators, which can be easily manipulated. S. typhimurium has been engineered and designed as cancer-targeting therapeutics, and can be improved by combining with other therapeutic methods, e.g. chemotherapy and radiotherapy, which regulate the tumor microenvironment synergistically. In view of all these strengths, the engineered attenuated strains have significant advantages for tumor diagnosis and treatment. This treatment has also been approved by the FDA for clinical trial. In this review, we summarized the recent progress and research in the field of Salmonella -mediated cancer therapy.
Keywords: Salmonella; bacterial-mediated cancer therapy; combination therapy; tumor microenvironment.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures







Similar articles
-
Targeted Cancer Therapy Using Engineered Salmonella typhimurium.Chonnam Med J. 2016 Sep;52(3):173-84. doi: 10.4068/cmj.2016.52.3.173. Epub 2016 Sep 23. Chonnam Med J. 2016. PMID: 27689027 Free PMC article. Review.
-
Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches.Front Oncol. 2021 Mar 2;11:624759. doi: 10.3389/fonc.2021.624759. eCollection 2021. Front Oncol. 2021. PMID: 33738260 Free PMC article. Review.
-
Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy.Cancer Lett. 2019 Apr 28;448:168-181. doi: 10.1016/j.canlet.2019.01.037. Epub 2019 Feb 10. Cancer Lett. 2019. PMID: 30753837 Review.
-
Salmonella as a Promising Curative Tool against Cancer.Pharmaceutics. 2022 Oct 1;14(10):2100. doi: 10.3390/pharmaceutics14102100. Pharmaceutics. 2022. PMID: 36297535 Free PMC article. Review.
-
Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.Cancer Lett. 2020 Jan 28;469:102-110. doi: 10.1016/j.canlet.2019.10.033. Epub 2019 Oct 24. Cancer Lett. 2020. PMID: 31666180 Review.
Cited by
-
Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?Microorganisms. 2022 Aug 27;10(9):1733. doi: 10.3390/microorganisms10091733. Microorganisms. 2022. PMID: 36144335 Free PMC article. Review.
-
Perspectives on Oncolytic Salmonella in Cancer Immunotherapy-A Promising Strategy.Front Immunol. 2021 Feb 25;12:615930. doi: 10.3389/fimmu.2021.615930. eCollection 2021. Front Immunol. 2021. PMID: 33717106 Free PMC article. Review.
-
Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy.J Nanobiotechnology. 2024 Jul 27;22(1):443. doi: 10.1186/s12951-024-02726-8. J Nanobiotechnology. 2024. PMID: 39068474 Free PMC article.
-
Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy.Acta Pharm Sin B. 2023 Feb;13(2):819-833. doi: 10.1016/j.apsb.2022.09.016. Epub 2022 Sep 25. Acta Pharm Sin B. 2023. PMID: 36873179 Free PMC article.
-
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy.J Nanobiotechnology. 2024 Aug 24;22(1):510. doi: 10.1186/s12951-024-02786-w. J Nanobiotechnology. 2024. PMID: 39182109 Free PMC article. Review.
References
-
- Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, SEER cancer statistics review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015. p. 2015.
-
- Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, Group EGW. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. 2012;23:vii11–vii9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources